万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://www.nature.com/jhh/
3、投稿网址：
https://mts-jhh.nature.com/cgi-bin/main.plex
4、官网邮箱：jhh@nature.com（编辑部）
5、期刊刊期：月刊，一年出版12期。
2021年8月10日星期二
投稿须知【官网信息】
Guide to Authors
To download our complete Guide to Authors as a pdf, please click here.
ABOUT THE JOURNAL
Aims and Scope
Journal of Human Hypertension is published monthly and is of interest to health care professionals who deal with hypertension (specialists, internists, primary care physicians) and public health workers. We believe that our patients benefit from robust scientific data that are based on well conducted clinical trials. We also believe that basic sciences are the foundations on which we build our knowledge of clinical conditions and their management. Towards this end, although we are primarily a clinical based journal, we also welcome suitable basic sciences studies that promote our understanding of human hypertension. The journal aims to perform the dual role of increasing knowledge in the field of high blood pressure as well as improving the standard of care of patients. The editors will consider for publication all suitable papers dealing directly or indirectly with clinical aspects of hypertension, including but not limited to epidemiology, pathophysiology, therapeutics and basic sciences involving human subjects or tissues. We also consider papers from all specialties such as ophthalmology, cardiology, nephrology, obstetrics and stroke medicine that deal with the various aspects of hypertension and its complications.
Journal Details
Editor-in-Chief: Michael Stowasser, University of Queensland, Brisbane, Australia
Editorial office: Springer Nature, The Campus, 4 Crinan Street, London, N1 9XW, UK, jhh@nature.com
Article Type Specifications
Article: Articles and Letters must include an extra table* to be named 'Summary Table', with two parts: firstly, the heading 'What is known about topic', and then secondly: 'What this study adds'. This should be two or three bullet points for each, with one or two short sentence for each bullet point. The objective of this is to provide the reader with a brief, quick and focused summary of your work in the perspective of other data [*Please note that this extra table is not required for clinical images/scans, reviews or Case Reports].The structure an Article should follow is detailed below.
Specifications: Unstructured abstract max. 250 words; Main body of text (excluding abstract, tables/figures, and references) not to exceed 4,000 words; Max 8 tables or figures; Max 35 references (please use as recent as possible)
Review Article: Detailed and comprehensive overcviews of the published literature. These should include a search strategy and Table(s) with a summary of the literature on a particular topic. Flow charts and figures illustrating mechanistic pathways and/or management strategies, as well as a section on 'clinical implications' should be included, where relevant. The Abstract (as for other articles) should state concisely the aim of the review, the main findings and the implications. Reviews can be solicited or sent in directly.
Specifications: Unstructured abstract max. 250 words; Main body of text (excluding abstract, tables/figures, and references) not to exceed 4,000 words; Liberal use of tables and figures is encouraged; Max 35 references
Letter: Brief reports of original data/observation, but can include case series and interesting clinical images/scans pertaining to hypertension. No Acknowledgements and continuous text with paragraphs but no subheadings
Specifications: After the title page (like articles), the text commences with 2 or 3 sentences providing an overview of the whole paper. These 2 or 3 sentences should be in bold, and so to serve as an 'abstract' - there is no separate formal abstract paragraph; Main body of text (excluding abstract, tables/figures, and references) not to exceed 1,200 words; Max 1 tables or figures; Max 12 references
Comment: These can discuss a particular paper published in the journal and set the problems addressed by the paper in the wider context of the field or portray your view on a topical or conversational subject in the field.
Specifications: No abstract required; Main body of text (excluding abstract, tables/figures, and references) not to exceed 1,500 words; Max 2 tables or figures; Max 15 references
Perspective: Perspectives are a hybrid between a commentary and a review, providing an opinion-driven perspective on a particular research topic or field of interest to the Journal of Human Hypertension readership. Authors should present a (provocative) view that can be supported by data and literature with the goal of sparking debate and stimulating future research avenues.
Specifications: No abstract required; Main body of text (excluding tables/figures, and references) not to exceed 2,000 words; Max of 4 tables and/or figures; Max 25 references
Correspondence: Pertaining to a current topic or a response to an article previously published.
Case Reports will be considered for publication as a 'Correspondence'. These would need to be very unusual cases, with a learning point or significant contribution to understanding of hypertension
Specifications: No abstract required; Main body of text (excluding tables/figures, and references) not to exceed 500 words for Correspondence and 750 words Case Report; Max 1 tables or figures; Max 10 references
Preparation of Articles
House Style: Authors should adhere to the following formatting guidelines
Text should be double spaced with a wide margin.
All pages and lines are to be numbered.
Do not make rules thinner than 1px (0.36mm).
Use a coarse hatching pattern rather than shading for tints in graphs.
Colour should be distinct when being used as an identifying tool.
Spaces, not commas should be used to separate thousands.
At first mention of a manufacturer, the town (and state if USA) and country should be provided.
Statistical methods: For normally distributed data, mean (SD) is the preferred summary statistic. Relative risks should be expressed as odds ratios with 95% confidence interval. To compare two methods for measuring a variable the method of Bland & Altman (1986, Lancet 1, 307–310) should be used; for this, calculation of P only is not appropriate.
Units: Use metric units (SI units) as fully as possible. Preferably give measurements of energy in kiloJoules or MegaJoules with kilocalories in parentheses (1 kcal = 4.186kJ). Use % throughout.
Abbreviations: On first using an abbreviation place it in parentheses after the full item. Very common abbreviations such as FFA, RNA, need not be defined. Note these abbreviations: gram g; litre l; milligram mg; kilogram kg; kilojoule kJ; megajoule MJ; weight wt; seconds s; minutes min; hours h. Do not add ‘s’ for plural units. Terms used less than four times should not be abbreviated.
Cover Letter: Authors should provide a cover letter that includes the affiliation and contact information for the corresponding author. Authors should briefly discuss the importance of the work and explain why it is considered appropriate for the diverse readership of the journal. The cover letter should confirm the material is original research, has not been previously published and has not been submitted for publication elsewhere while under consideration. If the manuscript has been previously considered for publication in another journal, please include the previous reviewer comments, to help expedite the decision by the Editorial team.
Title Page: The title page should contain:
Title of the paper - brief, informative, of 150 characters or less and should not make a statement or conclusion
Full names of all the authors and their affiliations, as well as the e-mail address of the corresponding author. If authors regard it as essential to indicate that two or more co-authors are equal in status, they may be identified by an asterisk symbol with the caption ‘These authors contributed equally to this work’ immediately under the address list.
Consortia: Please see Author Guide for full details on this.
Abstract: Articles must be prepared with an unstructured abstract designed to summarise the essential features of the paper in a logical and concise sequence.
Graphical Abstracts (optional): A graphical abstract, which summarizes the manuscript in a visual way, is designed to attract the attention of readers in the table of contents of the journal. Graphical abstracts are published in the table of contents and in the article. The graphic should be submitted as a single file using a standard file format (.tiff, .eps, .jpg, .bmp, .doc, or .pdf.), it should be 9 cm wide x 5 cm high when printed at full scale and a minimum of 300 dpi. All graphical abstracts should be submitted with a white background and imagery should fill the available width, whenever possible. Colour graphical abstracts are encouraged and will be published at no additional charge. Textual statements should be kept to a minimum.
Introduction: The Introduction should assume that the reader is knowledgeable in the field and should therefore be as brief as possible but can include a short historical review where desirable.
Materials/Subjects and Methods: This section should contain sufficient detail, so that all experimental procedures can be reproduced, and include references. Methods, however, that have been published in detail elsewhere should not be described in detail. Authors should provide the name of the manufacturer and their location for any specifically named medical equipment and instruments, and all drugs should be identified by their pharmaceutical names, and by their trade name if relevant.
Results: The Results section should briefly present the experimental data in text, tables or figures. Tables and figures should not be described extensively in the text.
Discussion: The Discussion should focus on the interpretation and the significance of the findings with concise objective comments that describe their relation to other work in the area. It should not repeat information in the results. The final paragraph should highlight the main conclusion(s), and provide some indication of the direction future research should take.
Data Availability: Please include a statement at the end of your paper that tells readers where the data generated or analysed during this study can be found e.g. within the published article and its supplementary files, within a recognised repository, with a link to the data in said repository, or if additional data are available from the corresponding author on reasonable request.
Please see the section on Research Data Policy in the Editorial Policies section for more information.
References: Only papers directly related to the article should be cited. Exhaustive lists should be avoided. References should follow the Vancouver format. In the text they should appear as numbers starting at one and at the end of the paper they should be listed (double-spaced) in numerical order corresponding to the order of citation in the text. Where a reference is to appear next to a number in the text, for example following an equation, chemical formula or biological acronym, citations should be written as (ref. X). Example “detectable levels of endogenous Bcl-2 (ref. 3), as confirmed by western blot”.
All authors should be listed for papers with up to six authors; for papers with more than six authors, the first six only should be listed, followed by et al. Abbreviations for titles of medical periodicals should conform to those used in the latest edition of Index Medicus. The first and last page numbers for each reference should be provided. Abstracts and letters must be identified as such. Papers in press may be included in the list of references.
Personal communications can be allocated a number and included in the list of references in the usual way or simply referred to in the text; the authors may choose which method to use. In either case authors must obtain permission from the individual concerned to quote his/her unpublished work.
……
更多详情：
https://www.nature.com/jhh/authors-and-referees/gta
